• Report Adverse Event or Product Quality Complaint
  • US Site
  • Global Site
AstraZeneca Medical Information
  • Therapy Areas
    • All Therapeutic Areas
    • Cardiovascular
    • Immunology
    • Infection
    • Metabolic
    • Oncology
    • Renal
    • Respiratory
    • Rare Disease (Alexion)
  • Medications
  • Resources
    • Congress Library
    • Disease Education
    • Pipeline
    • Clinical Trials
    • Open innovation
    • Access 360
    • Affordability Programs
    • Sample Closet
    • Medical Education Grant
    • Rare Disease (Alexion)
  • Connect
    • Connect with Us
    • Find an MSL
    • Request an MSL
    • Submit an MIR
    • Give Feedback
User
  • Login to My AZmedical
  • Register for My AZmedical

Search Medical Information

Immunology

AstraZeneca is pleased to present healthcare professionals with a variety of immunology resources for your informational purposes.
The educational materials are intended to provide disease-state information that can assist you in forming your own clinical and treatment decisions.

  1. Congress Library
  2. Medications
  3. Disease Education
  4. Continuing Education
  5. Pipeline

July 1-3, 2022

European Academy of Allergy and Clinical Immunology (EAACI) 2022

Explore AstraZeneca Scientific Materials Visit Congress Site

June 2-5, 2022

European Alliance of Associations for Rheumatology (EULAR) 2022

Explore AstraZeneca Scientific Materials Visit Congress Site

July 10-12, 2021

European Academy of Allergy and Clinical Immunology (EAACI) 2021

Explore AstraZeneca Scientific Materials Visit Congress Site

June 2-5, 2021

European Alliance of Associations for Rheumatology (EULAR) 2021

Explore AstraZeneca Scientific Materials Visit Congress Site
  • SAPHNELO(TM) (anifrolumab-fnia) Injection

VIDEO

VIDEO

What are the Causes of Irreversible Organ Damage in SLE

This video discusses the causes of irreversible organ damage in SLE


VIDEO

VIDEO

What Do You Find Exciting about the Type I Interferon Story in SLE?

This video discusses the type I interferon story in SLE.


VIDEO

VIDEO

Are There Differences In Type I Interferon Expression Based on Ethnicity

This video discusses whether there are differences in Type I interferon expression based on ethnicity


VIDEO

VIDEO

Is There a Role of Type I Interferon in Chronic SLE Disease?

This video discusses the role of type I Interferon in chronic SLE disease


VIDEO

VIDEO

Type I Interferon and Potential Links to SLE Clinical Manifestations

This video discusses type I interferon and potential links to SLE clinical manifestations


VIDEO

VIDEO

Interferon Gene Signature (IFNGS)

The video discusses the interferon gene signature (IFNGS)


VIDEO

VIDEO

Inadequate response to therapy in systemic lupus erythematosus

This video discusses inadequate response to therapy in patients with systemic lupus erythematosus.


podcast

10th Annual Basic & Clinical Immunology for the Busy PracCOVID-19 and Immune Mediated Inflammatory DiseasesImmunologic, Clinical, Therapeutic and Preventive Strategies at Two Years

Cleveland Clinic Educational Foundation

15-Mar-2022 to 15-Sept-2022

Webcast series developed from the live streamed conference consisting of 4 60-90 minute long webcasts

Learn More

e-Learning

COVID Round Up in Other IMIDS - Special Considerations

Cleveland Clinic Educational Foundation

15-Mar-2022 to 15-Sept-2022

Managing COVID-19 in patients with IMIDs Managing IMIDs in the era of COVID-19 COVID-19 autoimmunity, prevention, and management Rheumatic diseases and COVID-19

Learn More

e-Learning

Rheumatic Diseases and COVID-19

Cleveland Clinic Educational Foundation

15-Mar-2022 to 15-Sept-2022

Managing COVID-19 in patients with IMIDs Managing IMIDs in the era of COVID-19 COVID-19 autoimmunity, prevention, and management Rheumatic diseases and COVID-19

Learn More

e-Learning

Managing COVID-19 in IMIDS Patients

Cleveland Clinic Educational Foundation

15-Mar-2022 to 15-Sept-2022

Managing COVID-19 in patients with IMIDs Managing IMIDs in the era of COVID-19 COVID-19 autoimmunity, prevention, and management Rheumatic diseases and COVID-19

Learn More

e-learning

COVID-19 Autoimmunity, Prevention and Management

Cleveland Clinic Educational Foundation

15-Mar-2022 to 15-Sept-2022

Managing COVID-19 in patients with IMIDs Managing IMIDs in the era of COVID-19 COVID-19 autoimmunity, prevention, and management Rheumatic diseases and COVID-19

Learn More

Redirecting...

Welcome to AstraZeneca
Medical Information

The information provided on this site is intended for use by healthcare professionals practicing in the US. The dissemination of this information may be subject to different medical and regulatory requirements in other countries.

This web site is intended to help healthcare professionals practicing in the US and AstraZeneca authorized persons find scientifically balanced, evidence-based information about AstraZeneca drugs, submit a question, ask for field medical follow-up, and explore links to professional and patient support resources.

Are you a healthcare professional practicing in the United States?

I am an AstraZeneca authorized person   What is an AstraZeneca authorized person?This website is only intended for healthcare professionals practicing in the United States and authorized AstraZeneca personnel. AstraZeneca US Headquarters personnel and US Field Medical personnel are authorized to browse and search the database for their own background knowledge and insight. US Field Sales personnel should not access or browse this site. None of the content of this site should be directly linked or distributed without approval.
I am a payer or formulary decision-maker
I am neither (take me to AstraZeneca.com)
AstraZeneca Logo
Pharma Logo

This site is intended for healthcare professionals practicing in the US.

©2022 AstraZeneca. All rights reserved.

US-69609

Last Updated 11/22

Contact Us

About Us

AstraZeneca-US.com

Grant Opportunities

Survey Feedback

Your Privacy Choices

Privacy Notice

Legal Notice

Cookie Notice

US Site

Global Site

Report Adverse Event or Product Quality Complaint

Pharma Logo

Privacy NoticeLegal NoticeCookie Notice